Protéus, S.A.

Protéus is a leading biotechnology company dedicated to the discovery, design and production of novel proteins and protein-based products for worldwide markets of the life sciences and chemical industries. Our comprehensive offering includes:

Protein manufacturing, engineering and immunogenicity management: a broad range of tools and services provided by PSI (Protéus Services for Industry), a dedicated business unit created by Protéus to serve the pharmaceutical and biotech industry. APIs and intermediates manufactured using novel chemo-biocatalytic routes. To provide our clients with combined chemo-biocatalytic process R&D and multi-scale cGMP industrial manufacturing capabilities, Protéus has created PCAS Biosolution, a joint-venture formed with the European fine chemical company PCAS. Industrial partnerships to discover and develop improved products and processes and generate industrial property rights. Within industrial partnerships, we provide our partners with exclusivity to manufacture and commercialize the resulting products in their respective markets.

Using our proprietary biodiversity, protein engineering, immunogenicity management and manufacturing platform, we create significant value for our clients. Our goal is to help accelerate time-to-market, reduce cost of goods, create new intellectual property, and extend product lifecycle.